Related Experiment Video
Updated: Jun 27, 2026

11:58
Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
Modified citrus pectin anti-metastatic properties: one bullet, multiple targets
Vladislav V Glinsky1, Avraham Raz
1Harry S. Truman Memorial Veterans' Hospital, Columbia, MO 65201, USA.
Carbohydrate Research
|December 9, 2008
Summary
Modified citrus pectin (MCP) shows potential in cancer treatment by inhibiting metastasis and enhancing chemotherapy effects. This carbohydrate-based substance may offer new therapeutic strategies for various human malignancies.
Area of Science:
- Carbohydrate chemistry
- Oncology
- Molecular biology
Background:
- Cancer metastasis is a complex process involving multiple rate-limiting steps.
- Modified citrus pectin (MCP) is a water-soluble polysaccharide derived from citrus fruits.
- MCP undergoes modification via high pH and temperature treatments.
Purpose of the Study:
- To review the anti-cancer properties of MCP, focusing on its effects on metastasis.
- To explore MCP's anti-adhesive properties and its role in inducing tumor cell apoptosis.
- To discuss the potential of MCP as a therapeutic agent for human malignancies.
Main Methods:
- Literature review of studies on modified citrus pectin and cancer metastasis.
- Analysis of MCP's mechanism of action, including its interaction with galectin-3.
- Evaluation of MCP's anti-adhesive and pro-apoptotic effects on cancer cells.
Main Results:
- MCP exhibits anti-adhesive properties that can inhibit cancer cell spread.
- MCP may enhance tumor cell apoptosis by interfering with galectin-3's anti-apoptotic function.
- These properties suggest MCP's utility in combating various human cancers.
Conclusions:
- Modified citrus pectin (MCP) demonstrates significant potential as an anti-metastatic agent.
- MCP's ability to inhibit galectin-3 function offers a novel approach to cancer therapy.
- Further research into MCP could lead to new carbohydrate-based treatments for malignancies.

